Hikma Pharmaceuticals PLC – OTC:HKMPY
Hikma Pharmaceuticals stock price today
$49.2
-0.78
-1.58%
Financial Health
0
1
2
3
4
5
6
7
8
9
Market closed
Open in 1 day
Hikma Pharmaceuticals stock price monthly change
+0.58%
month
Hikma Pharmaceuticals stock price quarterly change
+0.58%
quarter
Hikma Pharmaceuticals stock price yearly change
+9.83%
year
Hikma Pharmaceuticals key metrics
Market Cap | 4.67B |
Enterprise value | 6.58B |
P/E | 39.31 |
EV/Sales | 2.19 |
EV/EBITDA | 10.27 |
Price/Sales | 1.84 |
Price/Book | 4.89 |
PEG ratio | -1.66 |
EPS | 3.38 |
Revenue | 5.44B |
EBITDA | 1.37B |
Income | 378.26M |
Revenue Q/Q | N/A |
Revenue Y/Y | N/A |
Profit margin | 9.47% |
Oper. margin | 15.84% |
Gross margin | 45.88% |
EBIT margin | 15.84% |
EBITDA margin | 25.28% |
Sign up &
create your own Smart Feed
create your own Smart Feed
Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.
Sign up for freeHikma Pharmaceuticals stock price history
Hikma Pharmaceuticals stock forecast
Hikma Pharmaceuticals financial statements
| Jun 2022 | 1.21B | 173M | 14.26% |
|---|---|---|---|
| Dec 2022 | 1.36B | 15.73M | 1.15% |
| Jun 2023 | 1.42B | 131M | 9.18% |
| Dec 2023 | 1.43B | 58.53M | 4.07% |
3.16%
Yield TTM
| Payout ratio | 55.5% |
|---|
| 2019 | 1.56% |
|---|---|
| 2020 | 1.35% |
| 2021 | 1.72% |
| 2022 | 3.02% |
| 2023 | 2.73% |
| Jun 2022 | 4747000000 | 2.55B | 53.84% |
|---|---|---|---|
| Dec 2022 | 4471000000 | 2.32B | 51.96% |
| Jun 2023 | 4619000000 | 2.41B | 52.33% |
| Dec 2023 | 4680000000 | 2.47B | 52.8% |
| Jun 2022 | 143M | -507M | 318M |
|---|---|---|---|
| Dec 2022 | 344.76M | -132.86M | -307.51M |
| Jun 2023 | 186M | -122M | -59M |
| Dec 2023 | 342.76M | -215.29M | -193.97M |
Hikma Pharmaceuticals alternative data
| Aug 2023 | 8,800 |
|---|---|
| Sep 2023 | 8,700 |
| Oct 2023 | 8,700 |
| Nov 2023 | 8,700 |
| Dec 2023 | 8,700 |
| Jan 2024 | 8,700 |
| Feb 2024 | 8,700 |
| Mar 2024 | 9,100 |
| Apr 2024 | 9,100 |
| May 2024 | 9,100 |
| Jun 2024 | 9,100 |
| Jul 2024 | 9,100 |
Hikma Pharmaceuticals other data
-
What's the price of Hikma Pharmaceuticals stock today?
One share of Hikma Pharmaceuticals stock can currently be purchased for approximately $49.2.
-
When is Hikma Pharmaceuticals's next earnings date?
Unfortunately, Hikma Pharmaceuticals's (HKMPY) next earnings date is currently unknown.
-
Does Hikma Pharmaceuticals pay dividends?
Yes, Hikma Pharmaceuticals pays dividends and its trailing 12-month yield is 3.16% with 55% payout ratio. The last Hikma Pharmaceuticals stock dividend of undefined was paid on 7 Sep 2025.
-
How much money does Hikma Pharmaceuticals make?
Hikma Pharmaceuticals has a market capitalization of 4.67B and it's past years’ income statements indicate that its last revenue has increased compared to the previous period by 14.22% to 2.88B US dollars.
-
What is Hikma Pharmaceuticals's stock symbol?
Hikma Pharmaceuticals PLC is traded on the OTC under the ticker symbol "HKMPY".
-
What is Hikma Pharmaceuticals's primary industry?
Company operates in the Healthcare sector and Drug Manufacturers—Specialty & Generic industry.
-
How do i buy shares of Hikma Pharmaceuticals?
Shares of Hikma Pharmaceuticals can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
-
How many employees does Hikma Pharmaceuticals have?
As Jul 2024, Hikma Pharmaceuticals employs 9,100 workers.
-
When Hikma Pharmaceuticals went public?
Hikma Pharmaceuticals PLC is publicly traded company for more then 15 years since IPO on 29 Sep 2009.
-
What is Hikma Pharmaceuticals's official website?
The official website for Hikma Pharmaceuticals is hikma.com.
-
How can i contact Hikma Pharmaceuticals?
Hikma Pharmaceuticals can be reached via phone at +44 20 7399 2760.
Hikma Pharmaceuticals company profile:
Hikma Pharmaceuticals PLC
hikma.comExchange:
OTC
Full time employees:
8,700
Industry:
Drug Manufacturers—Specialty & Generic
Sector:
Healthcare
Hikma Pharmaceuticals PLC develops, manufactures, markets, and sells a range of generic, branded, and in-licensed pharmaceutical products. The company offers its products in solid, semi-solid, liquid, and injectable final dosage forms. It operates through three segments: Injectables, Generics, and Branded. The Injectables segment provides generic injectable products primarily for use in hospitals. The Generics segment offers oral and other non-injectable generic products for the retail market. The Branded segment offers branded generics and in-licensed products to retail and hospital markets. The company provides its products in various therapeutic areas, including anti-infective, cardiovascular, central nervous system, diabetes, oncology, pain management, and respiratory. It operates in the United Kingdom, the United States, the Middle East, North Africa, Europe, and internationally. The company was founded in 1978 and is based in London, the United Kingdom.
1 New Burlington Place
London, W1S 2HR
London, W1S 2HR
:
ISIN: US4312881091
CUSIP: 431288109
